THE NOVO NORDISK UK RESEARCH FOUNDATION

Registered charity 1056410 · accounts filings on the Charity Commission register · Wikidata: Q30296686 · also known as NNUKRF, NOVO NORDISK UK RESEARCH FOUNDATION

* Promoting research into the causes and treatment of diabetes mellitus and publishing the useful result thereof.* The preservation and protection of the health of the public by educating them and conducting research into the causes and prevention of diabetes.* The advancement and promotion of education in the treatment of diabetes by members of the medical profession.

Objects

THE RELIEF OF SICKNESS GENERALLY IN THE UK AND IN PARTICULAR BUT NOT SO AS TO LIMIT THE GENERALITY OF THE FOREGOING: 1) PROMOTING RESEARCH INTO THE CAUSES AND TREATMENT OF DIABETES MELLITUS AND PUBLISHING THE USEFUL RESULTS THEREOF; 2) THE PRESERVATION AND PROTECTION OF THE HEALTH OF THE PUBLIC BY EDUCATING THEM AND CONDUCTING RESEARCH INTO THE CAUSES AND PREVENTION OF DIABETES; 3) THE ADVANCEMENT AND PROMOTION OF EDUCATION IN THE TREATMENT OF DIABETES BY MEMBERS OF THE MEDICAL PROFESSION.

Area of benefit: UNITED KINGDOM

The charity’s charitable objects and area of benefit, quoted from its governing document as held on the Charity Commission register.

Causes: Education/training · The Advancement Of Health Or Saving Of Lives · Grant history (this charity is a funder) · website · Get email alerts

Registered contact address: Crawley, South East, England (from the postcode on the register)

Latest income
£331k
Latest spending
£169k
Registered
1996
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that unrestricted reserves increased to £183,676, which the trustees consider sufficient to cover a year's expenditure. However, the filing notes that funding has only been secured through 2026, with no confirmation for 2027 or subsequent years, leading to a cessation of new awards from 2027 onwards.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Largest income source: Donations (89% of income)
“In 2025, £295,000 was received from the charity's sole donor, Novo Nordisk Limited” — page 4
Per its FY2025 accounts as filed with the Charity Commission.
Reserves policy: sufficient cash balance to cover expenditure for a year (reserves figure: £184k)
“It is the policy of the charity to maintain a sufficient cash balance to cover expenditure for a year.”
Per its FY2025 accounts as filed with the Charity Commission.
Going concern: noted by the trustees or auditor
“The trustees have not secured funding for 2027 or subsequent years and therefore will not be advertising awards for 2026 to ensure the Foundation has the funds to meet its existing award commitments.” — page 10
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Donated services from Novo Nordisk Limited
“From 21 April 2025 the secretary took over the administration for the charity under a contract of employment with Novo Nordisk Limited. The associated costs have been recognised in the accounts as a donated service.” — page 4
“In 2025, £295,000 was received from the charity's sole donor, Novo Nordisk Limited” — page 4
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Donations from Novo Nordisk Limited
“From 21 April 2025 the secretary took over the administration for the charity under a contract of employment with Novo Nordisk Limited. The associated costs have been recognised in the accounts as a donated service.” — page 4
“In 2025, £295,000 was received from the charity's sole donor, Novo Nordisk Limited” — page 4
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Trustee travel expenses
“From 21 April 2025 the secretary took over the administration for the charity under a contract of employment with Novo Nordisk Limited. The associated costs have been recognised in the accounts as a donated service.” — page 4
“In 2025, £295,000 was received from the charity's sole donor, Novo Nordisk Limited” — page 4
Per its FY2025 accounts as filed with the Charity Commission.

Accounts independently examined (not a full audit). Discloses 5 of 6 completeness components.

Year-over-year changes

Comparing this charity’s FY2024 and FY2025 accounts as analysed by this site.

Policies the charity declares

In its annual return the charity told the Commission that it has the policies listed below. This is self-declared: it is not verified by the Commission or by this site, and it is not evidence of how a policy works in practice.

From the charity’s annual return (Part A, self-declared)

Answers and figures the charity gave in Part A of its annual return to the Charity Commission. They are self-declared: not verified by the Commission or by this site. Only positive answers and figures are listed; items not listed are simply not shown.

Self-declared on the annual return for the financial year ending 31/12/2025

  • Volunteers: 22
  • Grant-making is its main activity

Self-declared on the annual return for the financial year ending 31/12/2024

  • Volunteers: 20
  • Grant-making is its main activity

Self-declared on the annual return for the financial year ending 31/12/2023

  • Volunteers: 18
  • Grant-making is its main activity

Source: this charity’s annual returns on the Charity Commission register.

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Northern Ireland · Scotland

Income and spending

Financial year endIncomeSpending
31/12/2025£331k£169k
31/12/2024£387k£285k
31/12/2023£273k£322k
31/12/2022£272k£327k
31/12/2021£255k£222k

Common questions

Is THE NOVO NORDISK UK RESEARCH FOUNDATION financially healthy?

Per its FY2025 accounts: The accounts state that unrestricted reserves increased to £183,676, which the trustees consider sufficient to cover a year's expenditure. However, the filing notes that funding has only been secured through 2026, with no confirmation for 2027 or subsequent years, leading to a cessation of new awards from 2027 onwards. Its FY2025 accounts were independently examined.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with DIABETES RESEARCH & WELLNESS FOUNDATION.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
THE NOVO NORDISK UK RESEARCH FOUNDATION£331k—0unclear—noted
DIABETES RESEARCH & WELLNESS FOUNDATION FY2025£1.3m£60,001 - £70,000—unclear—no doubt
EUROPEAN DIABETOLOGY FY2025£769k—0unclear—no doubt
THE INSULIN DEPENDENT DIABETES TRUST FY2025£476k—0unclear—no doubt
ISLE OF WIGHT DIABETIC FUND FY2025£30k—0above—no doubt
MEDICAL AND LIFE SCIENCES RESEARCH FUND FY2025£65k—0unclear—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.